Two methods–immunofluorescence and immunoblotting–were used for the detection of four molecular markers (β-catenin, filamin A, GAB1 and YAP1) in patient-derived cell lines to compare the results with those obtained from the corresponding tumor samples on the protein level. The gene discussed is FLNA; the disease is neoplasm.